87188-70-3

Basic information

• Product Name: Benzoic acid, 5-(1,1-dimethylethyl)-2-methoxy-, methyl ester
• CAS NO: 87188-70-3
• Molecular Formula: C13H18O3
• Molecular Weight: 222.284
• Mol File: 87188-70-3.mol
• Article Data: 3

Chemical Properties

• CAS DataBase Reference: Benzoic acid, 5-(1,1-dimethylethyl)-2-methoxy-, methyl ester(CAS DataBase Reference)
• NIST Chemistry Reference: Benzoic acid, 5-(1,1-dimethylethyl)-2-methoxy-, methyl ester(87188-70-3)
• EPA Substance Registry System: Benzoic acid, 5-(1,1-dimethylethyl)-2-methoxy-, methyl ester(87188-70-3)

Safety Data

• Hazardous Substances Data: 87188-70-3(Hazardous Substances Data)

Upstream product

• 74-88-4 methyl iodide 
• 2198-66-5 2-bromo-4-tert-butylphenol 
• 201230-82-2 carbon monoxide 
• 41280-65-3 2-bromo-4-tert-butylanisole 
• 507-19-7 t-butyl bromide 
• 7120-41-4 methyl 5-bromo-2-methoxybenzoate 

Downstream Products

• 73469-54-2 5-tert-butyl-2-methoxybenzoic acid 
• 160744-54-7 (5-(tert-butyl)-2-methoxyphenyl)methanol 
• 911060-73-6 2-(bromomethyl)-4-(tert-butyl)-1-methoxybenzene 
• 911060-75-8 1-(5-tert-butyl-2-methoxybenzyl)-5-chloro-1H-indole-2-carboxylic acid 
• 911060-74-7 1-(5-tert-butyl-2-methoxybenzyl)-5-chloro-1H-indole-2-carboxylic acid ethyl ester 

Relevant articles and documents

Substituted Pyrrolidines and Methods of Use

The invention discloses compounds of Formula (I) wherein R1, R2, R2A, R3, R3A, R4, and R5 are as defined herein. The present invention relates to compounds and their use in the treatment of cystic fibrosis, methods for their production, pharmaceutical compositions comprising the same, and methods of treating cystic fibrosis by administering a compound of the invention.

OPIOID RECEPTOR ACTIVE COMPOUNDS

The invention provides compounds of formula I: wherein R1 to R4 and n have any of the meanings defined in the specification and their pharmaceutically acceptable salts. The invention also provides pharmaceutical compositions comprising a compound of formula I, processes for preparing compounds of formula I, intermediates useful for preparing compounds of formula I, and therapeutic methods for treating pain and treating other conditions which involve, for example, binding opioid receptors using compounds of formula I.